Grifols, S.A. (BME:GRF)
12.90
-0.22 (-1.68%)
Aug 1, 2025, 9:45 AM CET
Augmedix Revenue
Grifols had revenue of 1.89B EUR in the quarter ending June 30, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 7.45B, up 9.32% year-over-year. In the year 2024, Grifols had annual revenue of 7.21B with 9.41% growth.
Revenue (ttm)
7.45B
Revenue Growth
+9.32%
P/S Ratio
1.07
Revenue / Employee
312.41K
Employees
23,833
Market Cap
7.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.21B | 620.41M | 9.41% |
Dec 31, 2023 | 6.59B | 528.01M | 8.71% |
Jan 1, 2023 | 6.06B | 1.13B | 22.92% |
Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
Dec 31, 2020 | 5.34B | 241.35M | 4.73% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Laboratorios Farmaceuticos Rovi | 749.00M |
Almirall | 1.05B |
Pharma Mar | 175.75M |
Faes Farma | 543.77M |
Clínica Baviera | 279.53M |
Laboratorio Reig Jofre | 333.55M |
Atrys Health | 218.10M |
Oryzon Genomics | 7.47M |
Grifols News
- 13 days ago - Grifols: Reassuring Evidence, Still On The Sidelines - Seeking Alpha
- 7 weeks ago - XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology - GlobeNewsWire
- 2 months ago - Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting - Business Wire
- 2 months ago - Grifols lawsuit against Gotham City to proceed after New York court ruling - Seeking Alpha
- 2 months ago - US court finds enough evidence to proceed with Grifols lawsuit against Gotham City - Reuters
- 2 months ago - Grifols: If This Works Out, It Has Massive Upside - Seeking Alpha
- 2 months ago - Grifols S.A. reports Q1 results - Seeking Alpha
- 2 months ago - Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha